Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eosinophil-guided Prednisone Administration in COPD Exacerbation Requiring Ventilatory Support

NCT03981081 is registered in ClinicalTrials.gov with Hôpital Universitaire Fattouma Bourguiba as lead sponsor.

NCT NCT03981081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03981081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eosinophil-guided Prednisone Administration in COPD Exacerbation Requiring Ventilatory Support
Lead sponsor
Hôpital Universitaire Fattouma Bourguiba
Phase
Phase 4
Overall status
Unknown status
Start date
April 2, 2019
Completion date
April 1, 2020
Enrollment
192 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation acute, mechanical ventilation